Anthera Pharmaceuticals Inc. (ANTH) OTC MARKETS
- - (-)
Market Cap: $2618
As of 03/14/24 04:00 PM EDT. Market closed.
Anthera Pharmaceuticals Inc. (ANTH)
OTC MARKETS
-
- (-)
Market Cap: $2618
As of 03/14/24 04:00 PM EDT. Market closed.
anthera pharmaceuticals, inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. anthera has two product candidates, sollpura, in phase 3 development for exocrine pancreatic insufficiency due to cystic fibrosis and blisibimod, in phase 2 development for iga nephropathy. nasdaq: ... read more
anthera pharmaceuticals, inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. anthera has two product candidates, sollpura, in phase 3 development for exocrine pancreatic insufficiency due to cystic fibrosis and blisibimod, in phase 2 development for iga nephropathy. nasdaq: anth read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
THOMPSON JOHN CRAIG | President & CEO | Sep 20, 2017 | Buy | $1.32 | 8,550 | 11,286 | 19,848 | Sep 20, 2017, 07:14 PM |
TRUEX PAUL F | Director | Sep 07, 2017 | Buy | $1.34 | 5,000 | 6,700 | 16,793 | Sep 07, 2017, 06:56 PM |
THOMPSON JOHN CRAIG | President & CEO | Sep 07, 2017 | Buy | $1.43 | 10,400 | 14,893 | 11,298 | Sep 07, 2017, 06:56 PM |
THOMPSON JOHN CRAIG | President & CEO | Sep 07, 2017 | Option Exercise | $1.43 | 10,400 | 14,893 | 17,590 | Sep 07, 2017, 02:43 PM |
TRUEX PAUL F | Chief Executive Officer | Sep 20, 2016 | Option Exercise | $2.08 | 5,008 | 10,417 | 5,008 | Sep 22, 2016, 07:29 PM |
Mueller Brian | Director | Dec 23, 2015 | Option Exercise | $2.89 | 10,000 | 28,900 | 10,000 | Dec 24, 2015, 12:35 PM |
Hislop Colin | Chief Medical Officer | Nov 13, 2015 | Option Exercise | $1.61 | 12,500 | 20,125 | 31,647 | Nov 18, 2015, 06:53 PM |
Hislop Colin | Chief Medical Officer | Nov 13, 2015 | Sale | $5.31 | 12,500 | 66,341 | 19,147 | Nov 18, 2015, 06:53 PM |
ODINK DEBRA | Chief Technology Officer | Oct 12, 2015 | Sale | $6.15 | 1,205 | 7,411 | 7,896 | Oct 13, 2015, 08:02 PM |
TRUEX PAUL F | President and CEO | Jun 30, 2014 | Option Exercise | $3.39 | 699 | 2,370 | 14,709 | Jul 01, 2014, 08:09 PM |
TRUEX PAUL F | President and CEO | Jun 30, 2014 | Option Exercise | $2.08 | 2,000 | 4,160 | 13,845 | Jul 01, 2014, 08:09 PM |
TRUEX PAUL F | President and CEO | Jun 30, 2013 | Option Exercise | $3.30 | 6,250 | 20,625 | 80,190 | Mar 28, 2014, 09:23 PM |
TRUEX PAUL F | President and CEO | Mar 25, 2014 | Option Exercise | $3.30 | 8,974 | 29,614 | 11,845 | Mar 28, 2014, 09:23 PM |
LIU MAY | Chief Accounting Officer | Mar 25, 2014 | Option Exercise | $3.30 | 529 | 1,746 | 3,677 | Mar 27, 2014, 09:57 PM |
ODINK DEBRA | Chief Technology Officer | Mar 25, 2014 | Option Exercise | $3.30 | 2,783 | 9,184 | 6,601 | Mar 27, 2014, 09:57 PM |
TRUEX PAUL F | President and CEO | Mar 25, 2014 | Option Exercise | $3.30 | 6,250 | 20,625 | 597,787 | Mar 27, 2014, 09:56 PM |
TRUEX PAUL F | President and CEO | Mar 25, 2014 | Option Exercise | $3.30 | 7,622 | 25,153 | 9,333 | Mar 27, 2014, 09:56 PM |
ODINK DEBRA | Chief Technology Officer | Jun 30, 2013 | Option Exercise | $0.49 | 2,248 | 1,102 | 75,074 | Jul 02, 2013, 09:17 PM |
LIU MAY | Chief Accounting Officer | Jun 30, 2013 | Option Exercise | $0.49 | 675 | 331 | 33,655 | Jul 02, 2013, 09:17 PM |
Thompson David E. | Director | Jun 24, 2013 | Buy | $0.53 | 100,000 | 53,000 | 128,201 | Jun 26, 2013, 05:24 PM |
DZIURZYNSKI BOGDAN | Director | May 31, 2013 | Buy | $0.59 | 10,000 | 5,900 | 10,000 | Jun 04, 2013, 07:26 PM |
ORBIMED ADVISORS LLC | Director | Jan 30, 2013 | Buy | $0.66 | 5,700,000 | 3,762,000 | 7,462,000 | Feb 01, 2013, 08:19 PM |
ORBIMED ADVISORS LLC | Director | Jan 25, 2013 | Buy | $0.65 | 1,762,000 | 1,142,481 | 1,762,000 | Jan 29, 2013, 04:54 PM |
TRUEX PAUL F | President and CEO | Jan 03, 2013 | Option Exercise | $0.69 | 17,454 | 12,043 | 66,412 | Jan 08, 2013, 05:29 PM |
KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | Jan 03, 2013 | Option Exercise | $0.69 | 2,410 | 1,663 | 30,035 | Jan 07, 2013, 09:20 PM |
ODINK DEBRA | Chief Technology Officer | Jan 03, 2013 | Option Exercise | $0.69 | 3,409 | 2,352 | 31,812 | Jan 07, 2013, 09:18 PM |
Hislop Colin | Chief Medical Officer | Jan 03, 2013 | Option Exercise | $0.69 | 4,560 | 3,146 | 84,959 | Jan 07, 2013, 09:17 PM |
LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | Jan 03, 2013 | Option Exercise | $0.69 | 8,660 | 5,975 | 41,336 | Jan 07, 2013, 09:17 PM |
KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | Jun 30, 2012 | Option Exercise | $0.69 | 2,068 | 1,427 | 24,601 | Jul 03, 2012, 07:27 PM |
ODINK DEBRA | Chief Technology Officer | Jun 30, 2012 | Option Exercise | $0.69 | 1,838 | 1,268 | 24,821 | Jul 03, 2012, 07:27 PM |
ORBIMED ADVISORS LLC | Director | Jun 29, 2012 | Sale | $0.73 | 1,283,300 | 942,071 | 0 | Jul 03, 2012, 03:19 PM |
HENNEY CHRISTOPHER S | Director | Jun 29, 2012 | Buy | $0.75 | 100,000 | 74,930 | 100,000 | Jul 02, 2012, 05:46 PM |
HENNEY CHRISTOPHER S | Director | Jun 29, 2012 | Buy | $0.75 | 100,000 | 74,930 | 202,429 | Jul 02, 2012, 05:46 PM |
TRUEX PAUL F | President and CEO | Jun 29, 2012 | Buy | $0.76 | 20,000 | 15,200 | 645,125 | Jul 02, 2012, 03:53 PM |
ORBIMED ADVISORS LLC | Director | Mar 22, 2012 | Sale | $2.40 | 1,306,700 | 3,140,131 | 1,283,300 | Mar 22, 2012, 06:15 PM |
ORBIMED ADVISORS LLC | Director | Mar 21, 2012 | Sale | $2.87 | 125,000 | 358,312 | 2,590,000 | Mar 22, 2012, 06:15 PM |
ORBIMED ADVISORS LLC | Director | Mar 20, 2012 | Sale | $2.90 | 116,800 | 338,638 | 2,715,000 | Mar 22, 2012, 06:15 PM |
ODINK DEBRA | Chief Technology Officer | Mar 01, 2012 | Sale | $6.57 | 2,000 | 13,140 | 26,659 | Mar 05, 2012, 04:01 PM |
Hislop Colin | Chief Medical Officer | Feb 23, 2012 | Option Exercise | $0.26 | 40,000 | 10,400 | 79,519 | Feb 27, 2012, 05:26 PM |
TRUEX PAUL F | President and C.E.O. | Feb 15, 2012 | Sale | $7.84 | 15,000 | 117,600 | 625,125 | Feb 17, 2012, 05:15 PM |
Hislop Colin | Chief Medical Officer | Feb 03, 2012 | Sale | $8.20 | 30,000 | 246,000 | 27,967 | Feb 06, 2012, 08:04 PM |
LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | Feb 01, 2012 | Sale | $7.66 | 15,000 | 114,900 | 31,151 | Feb 03, 2012, 04:01 PM |
ODINK DEBRA | Chief Technology Officer | Feb 01, 2012 | Sale | $7.67 | 2,000 | 15,340 | 21,241 | Feb 03, 2012, 04:01 PM |
TRUEX PAUL F | President and C.E.O. | Jan 31, 2012 | Option Exercise | $0.26 | 20,000 | 5,200 | 640,125 | Feb 02, 2012, 07:37 PM |
HEALY JAMES | Director | Jan 28, 2012 | Option Exercise | $4.19 | 12,000 | 50,280 | 32,443 | Jan 31, 2012, 05:53 PM |
TRUEX PAUL F | President and Chief Executive | Jan 17, 2012 | Sale | $6.75 | 15,000 | 101,250 | 627,125 | Jan 19, 2012, 05:03 PM |
ODINK DEBRA | Chief Technology Officer | Jan 10, 2012 | Sale | $6.51 | 800 | 5,205 | 23,241 | Jan 12, 2012, 12:58 PM |
ODINK DEBRA | Chief Technology Officer | Jan 06, 2012 | Sale | $6.50 | 1,200 | 7,800 | 24,441 | Jan 10, 2012, 02:27 PM |
HEALY JAMES | Director | Dec 30, 2011 | Sale | $6.22 | 25,000 | 155,625 | 3,298,684 | Jan 03, 2012, 08:31 PM |
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Dec 30, 2011 | Sale | $6.22 | 25,000 | 155,625 | 3,298,684 | Jan 03, 2012, 08:31 PM |
HEALY JAMES | Director | Dec 22, 2011 | Sale | $6.22 | 25,000 | 155,605 | 3,319,314 | Dec 23, 2011, 06:22 PM |
HEALY JAMES | Director | Dec 21, 2011 | Sale | $6.51 | 25,000 | 162,770 | 3,339,944 | Dec 23, 2011, 06:22 PM |
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Dec 22, 2011 | Sale | $6.22 | 25,000 | 155,605 | 3,319,314 | Dec 23, 2011, 06:22 PM |
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Dec 21, 2011 | Sale | $6.51 | 25,000 | 162,770 | 3,339,944 | Dec 23, 2011, 06:22 PM |
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Mar 04, 2010 | Option Exercise | $6.75 | 1,253,635 | 8,462,757 | 3,360,574 | Dec 22, 2011, 06:24 PM |
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Mar 04, 2010 | Option Exercise | $5.53 | 741,215 | 4,097,698 | 2,326,015 | Dec 22, 2011, 06:24 PM |
TRUEX PAUL F | President and CEO | Dec 15, 2011 | Sale | $6.34 | 15,000 | 95,065 | 642,125 | Dec 16, 2011, 09:53 PM |
ORBIMED ADVISORS LLC | Director | Dec 13, 2011 | Sale | $6.50 | 16,200 | 105,300 | 2,831,800 | Dec 13, 2011, 06:37 PM |
ORBIMED ADVISORS LLC | Director | Dec 09, 2011 | Sale | $6.75 | 40,000 | 270,000 | 2,848,000 | Dec 13, 2011, 06:37 PM |
ORBIMED ADVISORS LLC | Director | Nov 16, 2011 | Sale | $6.87 | 25,000 | 171,750 | 2,915,000 | Nov 18, 2011, 05:57 PM |
ORBIMED ADVISORS LLC | Director | Nov 18, 2011 | Sale | $6.50 | 3,000 | 19,500 | 2,888,000 | Nov 18, 2011, 05:57 PM |
ORBIMED ADVISORS LLC | Director | Nov 17, 2011 | Sale | $6.67 | 24,000 | 160,080 | 2,891,000 | Nov 18, 2011, 05:57 PM |
TRUEX PAUL F | President and CEO | Nov 15, 2011 | Sale | $6.96 | 30,000 | 208,704 | 672,125 | Nov 17, 2011, 04:01 PM |
ORBIMED ADVISORS LLC | Director | Nov 11, 2011 | Sale | $7.14 | 5,000 | 35,700 | 2,995,000 | Nov 15, 2011, 06:29 PM |
ORBIMED ADVISORS LLC | Director | Nov 15, 2011 | Sale | $6.93 | 50,000 | 346,500 | 2,940,000 | Nov 15, 2011, 06:29 PM |
ORBIMED ADVISORS LLC | Director | Nov 14, 2011 | Sale | $6.95 | 5,000 | 34,750 | 2,990,000 | Nov 15, 2011, 06:29 PM |
Hislop Colin | Chief Medical Officer | Nov 08, 2011 | Option Exercise | $0.26 | 15,000 | 3,900 | 72,967 | Nov 10, 2011, 05:06 PM |
Hislop Colin | Chief Medical Officer | Nov 08, 2011 | Sale | $6.74 | 15,000 | 101,163 | 57,967 | Nov 10, 2011, 05:06 PM |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Nov 03, 2011 | Sale | $6.88 | 15,000 | 103,236 | 46,151 | Nov 04, 2011, 08:24 PM |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Oct 25, 2011 | Sale | $7.07 | 4,637 | 32,784 | 0 | Oct 27, 2011, 07:48 PM |
TRUEX PAUL F | President and CEO | Oct 21, 2011 | Sale | $6.25 | 23,235 | 145,219 | 649,004 | Oct 25, 2011, 09:55 PM |
TRUEX PAUL F | President and CEO | Oct 18, 2011 | Sale | $6.25 | 6,745 | 42,156 | 660,360 | Oct 20, 2011, 09:28 PM |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Aug 08, 2011 | Option Exercise | $1.34 | 10,000 | 13,400 | 61,151 | Aug 09, 2011, 06:21 PM |
TRUEX PAUL F | President and CEO | Aug 08, 2011 | Option Exercise | $0.26 | 50,000 | 13,000 | 90,512 | Aug 09, 2011, 06:16 PM |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Aug 03, 2011 | Sale | $6.88 | 14,600 | 100,432 | 51,151 | Aug 04, 2011, 08:08 PM |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Aug 02, 2011 | Sale | $7.31 | 5,000 | 36,571 | 4,937 | Aug 04, 2011, 08:08 PM |
TRUEX PAUL F | President and CEO | Jul 15, 2011 | Sale | $7.95 | 15,000 | 119,258 | 667,125 | Jul 18, 2011, 05:40 PM |
Hislop Colin | Chief Medical Officer | Jul 12, 2011 | Option Exercise | $0.26 | 15,000 | 3,900 | 57,967 | Jul 14, 2011, 04:15 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | Jul 07, 2011 | Option Exercise | $2.42 | 19,563 | 47,264 | 5,357,528 | Jul 11, 2011, 05:49 PM |
TRUEX PAUL F | President and CEO | Jun 30, 2011 | Option Exercise | $8.17 | 48,500 | 396,245 | 40,512 | Jul 05, 2011, 06:37 PM |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Jun 30, 2011 | Option Exercise | $8.17 | 23,500 | 191,995 | 65,751 | Jul 05, 2011, 06:34 PM |
KILFOIL GEORGINA | SVP, Prod. Dev. & Project Mngm | Jun 30, 2011 | Option Exercise | $8.17 | 5,625 | 45,956 | 16,875 | Jul 05, 2011, 06:31 PM |
Hislop Colin | Chief Medical Officer | Jun 30, 2011 | Option Exercise | $8.17 | 17,500 | 142,975 | 42,967 | Jul 05, 2011, 06:28 PM |
ODINK DEBRA | VP, Pharmaceutical R&D | Jun 30, 2011 | Option Exercise | $8.17 | 3,670 | 29,984 | 25,641 | Jul 05, 2011, 06:23 PM |
Hislop Colin | Chief Medical Officer | Jun 29, 2011 | Option Exercise | $0.26 | 10,000 | 2,600 | 60,062 | Jun 30, 2011, 08:06 PM |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Jun 21, 2011 | Option Exercise | $1.31 | 20,000 | 26,200 | 87,645 | Jun 22, 2011, 08:11 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | Jun 16, 2011 | Sale | $8.67 | 3,100 | 26,877 | 4,836,202 | Jun 20, 2011, 05:46 PM |
TRUEX PAUL F | President and CEO | Jun 15, 2011 | Sale | $8.30 | 15,000 | 124,539 | 682,125 | Jun 17, 2011, 07:50 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | Jun 14, 2011 | Sale | $8.81 | 699 | 6,158 | 4,839,011 | Jun 15, 2011, 08:21 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | Jun 13, 2011 | Sale | $8.80 | 1,300 | 11,440 | 4,839,645 | Jun 15, 2011, 08:21 PM |
ORBIMED ADVISORS LLC | Director | Jun 10, 2011 | Sale | $8.18 | 30,000 | 245,400 | 3,000,000 | Jun 10, 2011, 06:28 PM |
ORBIMED ADVISORS LLC | Director | Jun 09, 2011 | Sale | $8.11 | 37,000 | 300,070 | 3,030,000 | Jun 10, 2011, 06:28 PM |
ORBIMED ADVISORS LLC | Director | Jun 08, 2011 | Sale | $8.02 | 33,000 | 264,660 | 3,067,000 | Jun 10, 2011, 06:28 PM |
ORBIMED ADVISORS LLC | Director | May 18, 2011 | Sale | $8.03 | 69,334 | 556,752 | 3,139,000 | Jun 06, 2011, 06:19 AM |
ORBIMED ADVISORS LLC | Director | May 17, 2011 | Sale | $8.32 | 100,000 | 832,000 | 3,208,334 | Jun 06, 2011, 06:19 AM |
ORBIMED ADVISORS LLC | Director | May 16, 2011 | Sale | $7.20 | 12,000 | 86,400 | 3,308,334 | Jun 06, 2011, 06:19 AM |
ORBIMED ADVISORS LLC | Director | May 11, 2011 | Sale | $7.22 | 13,000 | 93,860 | 3,320,334 | Jun 06, 2011, 06:16 AM |
ORBIMED ADVISORS LLC | Director | May 10, 2011 | Sale | $7.23 | 106,400 | 769,272 | 3,333,334 | Jun 06, 2011, 06:16 AM |
ORBIMED ADVISORS LLC | Director | May 09, 2011 | Sale | $7.26 | 10,000 | 72,600 | 3,439,734 | Jun 06, 2011, 06:16 AM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 26, 2011 | Sale | $8.60 | 4,800 | 41,280 | 4,840,823 | May 31, 2011, 07:31 PM |
ORBIMED ADVISORS LLC | Director | May 26, 2011 | Sale | $8.53 | 34,200 | 291,726 | 3,100,000 | May 27, 2011, 06:58 PM |
ORBIMED ADVISORS LLC | Director | May 25, 2011 | Sale | $8.65 | 4,800 | 41,520 | 3,134,200 | May 27, 2011, 06:58 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 25, 2011 | Sale | $8.67 | 32,750 | 283,943 | 4,845,172 | May 25, 2011, 06:42 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 24, 2011 | Sale | $8.42 | 52,196 | 439,490 | 4,874,844 | May 25, 2011, 06:42 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 23, 2011 | Sale | $8.18 | 26,703 | 218,431 | 4,922,134 | May 25, 2011, 06:42 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 19, 2011 | Sale | $8.03 | 125,000 | 1,003,750 | 4,946,327 | May 19, 2011, 06:23 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 17, 2011 | Sale | $8.29 | 13,900 | 115,231 | 5,059,578 | May 19, 2011, 06:23 PM |
TRUEX PAUL F | President and CEO | May 16, 2011 | Sale | $7.16 | 15,000 | 107,339 | 692,003 | May 18, 2011, 07:28 PM |
ORBIMED ADVISORS LLC | Director | May 18, 2011 | Sale | $8.03 | 69,334 | 556,752 | 3,139,000 | May 18, 2011, 07:12 PM |
ORBIMED ADVISORS LLC | Director | May 17, 2011 | Sale | $8.32 | 100,000 | 832,000 | 3,208,334 | May 18, 2011, 07:12 PM |
ORBIMED ADVISORS LLC | Director | May 16, 2011 | Sale | $7.20 | 12,000 | 86,400 | 3,308,334 | May 18, 2011, 07:12 PM |
ORBIMED ADVISORS LLC | Director | May 10, 2011 | Sale | $7.23 | 106,400 | 769,272 | 3,333,334 | May 11, 2011, 08:21 PM |
ORBIMED ADVISORS LLC | Director | May 09, 2011 | Sale | $7.26 | 10,000 | 72,600 | 3,439,734 | May 11, 2011, 08:21 PM |
ORBIMED ADVISORS LLC | Director | May 11, 2011 | Sale | $7.22 | 13,000 | 93,860 | 3,320,334 | May 11, 2011, 08:21 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 05, 2011 | Sale | $7.01 | 387,700 | 2,717,777 | 5,072,171 | May 05, 2011, 05:36 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 04, 2011 | Sale | $7.00 | 200,000 | 1,400,000 | 5,423,428 | May 05, 2011, 05:36 PM |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 03, 2011 | Sale | $7.00 | 100,000 | 700,000 | 5,604,628 | May 05, 2011, 05:36 PM |
ODINK DEBRA | VP, Pharmaceutical R&D | Apr 13, 2011 | Option Exercise | $1.51 | 3,311 | 5,000 | 29,311 | Apr 14, 2011, 08:36 PM |
TRUEX PAUL F | President and CEO | Apr 13, 2011 | Option Exercise | $0.26 | 30,000 | 7,800 | 121,122 | Apr 14, 2011, 08:35 PM |
Thompson David E. | Director | Jan 03, 2011 | Option Exercise | $1.39 | 11,558 | 16,067 | 11,558 | Jan 05, 2011, 08:50 PM |
ORBIMED ADVISORS LLC | 10% Owner | Sep 30, 2010 | Buy | $4.08 | 19,900 | 81,192 | 3,449,734 | Oct 04, 2010, 08:08 PM |
ODINK DEBRA | VP, Pharmaceutical R&D | Sep 24, 2010 | Buy | $4.20 | 1,000 | 4,200 | 26,000 | Sep 24, 2010, 09:22 PM |
LOWE CHRISTOPHER P. | CFO & VP of Administration | Sep 24, 2010 | Buy | $4.18 | 5,000 | 20,900 | 62,523 | Sep 24, 2010, 09:20 PM |
Leheny A. Rachel | Director | Sep 24, 2010 | Buy | $3.00 | 250,000 | 750,000 | 1,423,896 | Sep 24, 2010, 09:19 PM |
Trias Joaquim | Sr. VP, Preclinical Developmen | Sep 21, 2010 | Option Exercise | $1.51 | 4,380 | 6,614 | 198,546 | Sep 23, 2010, 08:44 PM |
Hislop Colin | Sr. VP, Cardiovasc. Prod. | Sep 21, 2010 | Option Exercise | $0.26 | 14,683 | 3,818 | 15,183 | Sep 23, 2010, 08:40 PM |
Hislop Colin | Sr. VP, Cardiovasc. Prod. | Aug 18, 2010 | Buy | $4.80 | 500 | 2,400 | 500 | Aug 20, 2010, 02:37 PM |
Owner | Relationship | Date | Value($) |
THOMPSON JOHN CRAIG | President & CEO | 09/20/2017 | 11,286 |
TRUEX PAUL F | Director | 09/07/2017 | 6,700 |
THOMPSON JOHN CRAIG | President & CEO | 09/07/2017 | 14,893 |
THOMPSON JOHN CRAIG | President & CEO | 09/07/2017 | 14,893 |
TRUEX PAUL F | Chief Executive Officer | 09/20/2016 | 10,417 |
Mueller Brian | Director | 12/23/2015 | 28,900 |
Hislop Colin | Chief Medical Officer | 11/13/2015 | 20,125 |
Hislop Colin | Chief Medical Officer | 11/13/2015 | 66,341 |
ODINK DEBRA | Chief Technology Officer | 10/12/2015 | 7,411 |
TRUEX PAUL F | President and CEO | 06/30/2014 | 2,370 |
TRUEX PAUL F | President and CEO | 06/30/2014 | 4,160 |
TRUEX PAUL F | President and CEO | 06/30/2013 | 20,625 |
TRUEX PAUL F | President and CEO | 03/25/2014 | 29,614 |
LIU MAY | Chief Accounting Officer | 03/25/2014 | 1,746 |
ODINK DEBRA | Chief Technology Officer | 03/25/2014 | 9,184 |
TRUEX PAUL F | President and CEO | 03/25/2014 | 20,625 |
TRUEX PAUL F | President and CEO | 03/25/2014 | 25,153 |
ODINK DEBRA | Chief Technology Officer | 06/30/2013 | 1,102 |
LIU MAY | Chief Accounting Officer | 06/30/2013 | 331 |
Thompson David E. | Director | 06/24/2013 | 53,000 |
DZIURZYNSKI BOGDAN | Director | 05/31/2013 | 5,900 |
ORBIMED ADVISORS LLC | Director | 01/30/2013 | 3,762,000 |
ORBIMED ADVISORS LLC | Director | 01/25/2013 | 1,142,481 |
TRUEX PAUL F | President and CEO | 01/03/2013 | 12,043 |
KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | 01/03/2013 | 1,663 |
ODINK DEBRA | Chief Technology Officer | 01/03/2013 | 2,352 |
Hislop Colin | Chief Medical Officer | 01/03/2013 | 3,146 |
LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | 01/03/2013 | 5,975 |
KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | 06/30/2012 | 1,427 |
ODINK DEBRA | Chief Technology Officer | 06/30/2012 | 1,268 |
ORBIMED ADVISORS LLC | Director | 06/29/2012 | 942,071 |
HENNEY CHRISTOPHER S | Director | 06/29/2012 | 74,930 |
HENNEY CHRISTOPHER S | Director | 06/29/2012 | 74,930 |
TRUEX PAUL F | President and CEO | 06/29/2012 | 15,200 |
ORBIMED ADVISORS LLC | Director | 03/22/2012 | 3,140,131 |
ORBIMED ADVISORS LLC | Director | 03/21/2012 | 358,312 |
ORBIMED ADVISORS LLC | Director | 03/20/2012 | 338,638 |
ODINK DEBRA | Chief Technology Officer | 03/01/2012 | 13,140 |
Hislop Colin | Chief Medical Officer | 02/23/2012 | 10,400 |
TRUEX PAUL F | President and C.E.O. | 02/15/2012 | 117,600 |
Hislop Colin | Chief Medical Officer | 02/03/2012 | 246,000 |
LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | 02/01/2012 | 114,900 |
ODINK DEBRA | Chief Technology Officer | 02/01/2012 | 15,340 |
TRUEX PAUL F | President and C.E.O. | 01/31/2012 | 5,200 |
HEALY JAMES | Director | 01/28/2012 | 50,280 |
TRUEX PAUL F | President and Chief Executive | 01/17/2012 | 101,250 |
ODINK DEBRA | Chief Technology Officer | 01/10/2012 | 5,205 |
ODINK DEBRA | Chief Technology Officer | 01/06/2012 | 7,800 |
HEALY JAMES | Director | 12/30/2011 | 155,625 |
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 12/30/2011 | 155,625 |
HEALY JAMES | Director | 12/22/2011 | 155,605 |
HEALY JAMES | Director | 12/21/2011 | 162,770 |
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 12/22/2011 | 155,605 |
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 12/21/2011 | 162,770 |
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 03/04/2010 | 8,462,757 |
SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 03/04/2010 | 4,097,698 |
TRUEX PAUL F | President and CEO | 12/15/2011 | 95,065 |
ORBIMED ADVISORS LLC | Director | 12/13/2011 | 105,300 |
ORBIMED ADVISORS LLC | Director | 12/09/2011 | 270,000 |
ORBIMED ADVISORS LLC | Director | 11/16/2011 | 171,750 |
ORBIMED ADVISORS LLC | Director | 11/18/2011 | 19,500 |
ORBIMED ADVISORS LLC | Director | 11/17/2011 | 160,080 |
TRUEX PAUL F | President and CEO | 11/15/2011 | 208,704 |
ORBIMED ADVISORS LLC | Director | 11/11/2011 | 35,700 |
ORBIMED ADVISORS LLC | Director | 11/15/2011 | 346,500 |
ORBIMED ADVISORS LLC | Director | 11/14/2011 | 34,750 |
Hislop Colin | Chief Medical Officer | 11/08/2011 | 3,900 |
Hislop Colin | Chief Medical Officer | 11/08/2011 | 101,163 |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 11/03/2011 | 103,236 |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 10/25/2011 | 32,784 |
TRUEX PAUL F | President and CEO | 10/21/2011 | 145,219 |
TRUEX PAUL F | President and CEO | 10/18/2011 | 42,156 |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 08/08/2011 | 13,400 |
TRUEX PAUL F | President and CEO | 08/08/2011 | 13,000 |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 08/03/2011 | 100,432 |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 08/02/2011 | 36,571 |
TRUEX PAUL F | President and CEO | 07/15/2011 | 119,258 |
Hislop Colin | Chief Medical Officer | 07/12/2011 | 3,900 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 07/07/2011 | 47,264 |
TRUEX PAUL F | President and CEO | 06/30/2011 | 396,245 |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 06/30/2011 | 191,995 |
KILFOIL GEORGINA | SVP, Prod. Dev. & Project Mngm | 06/30/2011 | 45,956 |
Hislop Colin | Chief Medical Officer | 06/30/2011 | 142,975 |
ODINK DEBRA | VP, Pharmaceutical R&D | 06/30/2011 | 29,984 |
Hislop Colin | Chief Medical Officer | 06/29/2011 | 2,600 |
LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 06/21/2011 | 26,200 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 06/16/2011 | 26,877 |
TRUEX PAUL F | President and CEO | 06/15/2011 | 124,539 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 06/14/2011 | 6,158 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 06/13/2011 | 11,440 |
ORBIMED ADVISORS LLC | Director | 06/10/2011 | 245,400 |
ORBIMED ADVISORS LLC | Director | 06/09/2011 | 300,070 |
ORBIMED ADVISORS LLC | Director | 06/08/2011 | 264,660 |
ORBIMED ADVISORS LLC | Director | 05/18/2011 | 556,752 |
ORBIMED ADVISORS LLC | Director | 05/17/2011 | 832,000 |
ORBIMED ADVISORS LLC | Director | 05/16/2011 | 86,400 |
ORBIMED ADVISORS LLC | Director | 05/11/2011 | 93,860 |
ORBIMED ADVISORS LLC | Director | 05/10/2011 | 769,272 |
ORBIMED ADVISORS LLC | Director | 05/09/2011 | 72,600 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/26/2011 | 41,280 |
ORBIMED ADVISORS LLC | Director | 05/26/2011 | 291,726 |
ORBIMED ADVISORS LLC | Director | 05/25/2011 | 41,520 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/25/2011 | 283,943 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/24/2011 | 439,490 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/23/2011 | 218,431 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/19/2011 | 1,003,750 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/17/2011 | 115,231 |
TRUEX PAUL F | President and CEO | 05/16/2011 | 107,339 |
ORBIMED ADVISORS LLC | Director | 05/18/2011 | 556,752 |
ORBIMED ADVISORS LLC | Director | 05/17/2011 | 832,000 |
ORBIMED ADVISORS LLC | Director | 05/16/2011 | 86,400 |
ORBIMED ADVISORS LLC | Director | 05/10/2011 | 769,272 |
ORBIMED ADVISORS LLC | Director | 05/09/2011 | 72,600 |
ORBIMED ADVISORS LLC | Director | 05/11/2011 | 93,860 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/05/2011 | 2,717,777 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/04/2011 | 1,400,000 |
VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/03/2011 | 700,000 |
ODINK DEBRA | VP, Pharmaceutical R&D | 04/13/2011 | 5,000 |
TRUEX PAUL F | President and CEO | 04/13/2011 | 7,800 |
Thompson David E. | Director | 01/03/2011 | 16,067 |
ORBIMED ADVISORS LLC | 10% Owner | 09/30/2010 | 81,192 |
ODINK DEBRA | VP, Pharmaceutical R&D | 09/24/2010 | 4,200 |
LOWE CHRISTOPHER P. | CFO & VP of Administration | 09/24/2010 | 20,900 |
Leheny A. Rachel | Director | 09/24/2010 | 750,000 |
Trias Joaquim | Sr. VP, Preclinical Developmen | 09/21/2010 | 6,614 |
Hislop Colin | Sr. VP, Cardiovasc. Prod. | 09/21/2010 | 3,818 |
Hislop Colin | Sr. VP, Cardiovasc. Prod. | 08/18/2010 | 2,400 |